Innovating Viral Vector Production Platforms for Gene Therapy Applications
Gene therapy has been around for over decades, and its potential serves as a silver lining to many people with genetic diseases and different types of cancer. The main advantage of gene therapy that outweighs its disadvantages is the promise of providing patients a life free of regular therapies and disease management.
With the aim of improving more lives, Esco offers a series of viral vector CDMO services for early-stage gene therapy research, preclinical phase trial, clinical phase trial, and commercial manufacturing. Our top priority is to use our expertise and streamline our platform processes to meet your specific needs.
-
Cell Preparation and Thawing
-
Upstream Bioprocessing (Cell Seeding, Culture, Expansion and Harvest)
-
Downstream Bioprocessing and Quality Controls
-
Formulation and Filling
-
Labeling and Packaging
-
Storage
